Swedish Real Estate Stock News

Cheffelo's (STO:CHEF) stock is up by a considerable 24% over the past month. As most would know, fundamentals are what...

With a price-to-earnings (or "P/E") ratio of 62.5x Haypp Group AB (publ) ( STO:HAYPP ) may be sending very bearish...

The recent 10% drop in Candles Scandinavia AB (publ)'s ( STO:CANDLE B ) stock could come as a blow to insiders who...

While Arjo AB (publ) ( STO:ARJO B ) might not have the largest market cap around , it saw its share price hover around...

It hasn't been the best quarter for Metacon AB (publ) ( STO:META ) shareholders, since the share price has fallen 26...

Key Insights Significant control over Volati by individual investors implies that the general public has more power to...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Invisio fair value estimate is kr403 Invisio's kr313 share...

Key Insights The projected fair value for Starbreeze is kr0.12 based on 2 Stage Free Cash Flow to Equity Current share...

Key Insights Given the large stake in the stock by institutions, Bufab's stock price might be vulnerable to their...

Key Insights Lifco's significant insider ownership suggests inherent interests in company's expansion The largest...

To the annoyance of some shareholders, Acuvi AB ( STO:ACUVI ) shares are down a considerable 26% in the last month...

Gruvaktiebolaget Viscaria ( STO:VISC ) shareholders are no doubt pleased to see that the share price has bounced 41% in...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Camurus AB (publ) recently announced that the U.S. FDA has accepted for review its resubmitted New Drug Application for Oclaiz (CAM2029), an extended-release octreotide injection for acromegaly, with a PDUFA target action date set for 10 June 2026. This acceptance helps clear a prior hurdle tied to third-party manufacturing observations and follows earlier EU and UK approvals and launch of the same product, marketed there as Oczyesa. We will now examine how FDA acceptance of the Oclaiz...

The European market has shown resilience, with the pan-European STOXX Europe 600 Index ending higher, buoyed by strong economic data and earnings results. As small-cap stocks continue to attract attention in this environment, identifying those with solid fundamentals and insider activity can offer intriguing opportunities for investors seeking potential value.

Amidst a mixed performance in major European stock indexes, with the STOXX Europe 600 Index ending slightly higher due to resilient economic data and earnings results, investors are keenly observing opportunities for undervalued stocks. In this environment, identifying stocks trading at estimated discounts can be attractive for those looking to capitalize on market inefficiencies and potential growth prospects.

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

The Net Insight AB (publ) ( STO:NETI B ) share price has had a bad week, falling 11%. But that doesn't change the fact...

When close to half the companies in Sweden have price-to-earnings ratios (or "P/E's") below 22x, you may consider Sweco...

Investment AB Latour (publ) ( STO:LATO B ) saw significant share price movement during recent months on the OM, rising...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Why Nobia’s rights issue and UK exit matter for shareholders Nobia (OM:NOBI) is overhauling its business by selling its UK operations, refocusing on Nordic markets, and raising approximately SEK 1.5b through a rights issue, together with new loan agreements and planned capital structure changes. See our latest analysis for Nobia. The rights issue, UK exit and refinancing have come against a weak share price backdrop, with a 7 day share price return of 27.12% decline and a 5 year total...